Partial genomic profiling (PCR EGFR and/or FISH/IHC ALK and/or ROS1) was obtained in an additional 23 cases (24%), seven of which were squamous cell carcinomas where EGFR status alone was considered sufficient for treatment decision. Here, ROS1 is linked to squamous cell carcinoma.